New MSF report shows unacceptable global double standard in diabetes care, even though better treatments cost little to produce and could be much more affordable

In precedent-setting move towards drug-development cost transparency, MSF reveals cost of its landmark TB clinical trial: €34 million

Colombia issues first-ever compulsory license, a landmark step for expanding access to affordable HIV treatment

As Danaher reports quarterly earnings and increased market share for Cepheid’s GeneXpert medical tests, MSF calls on corporation to drop all test prices to $5 for low- and middle-income countries

As Gavi plans next five-year strategy, it must do more to get vaccines to people excluded from vaccination

New MSF costing study in JAMA reveals dramatic markup on prices of new diabetes medicines and insulin pens

‘Time for Five’ coalition launches global petition targeting medical test maker Cepheid and parent corporation Danaher

MSF calls for emergency stockpile of Ebola treatments ten years after world’s deadliest outbreak